{
    "2020-12-14": [
        [
            {
                "time": "",
                "original_text": "泰格医药大宗交易成交2070万元，买卖双方均为机构专用席位",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "大宗交易",
                        "机构专用席位"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药今日大宗交易成交15万股，成交价138.0元溢价0.0%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "大宗交易",
                        "溢价"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：2021医药“春季躁动”有望提前到来 关注医药消费投资机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "春季躁动",
                        "投资机会"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：把握中国优势 就是把握明年行情",
                "features": {
                    "keywords": [
                        "医药行业",
                        "中国优势",
                        "行情"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中银国际首予泰格医药(03347-HK)目标价170港元买入评级",
                "features": {
                    "keywords": [
                        "中银国际",
                        "泰格医药",
                        "目标价",
                        "买入评级"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}